Peer-reviewed study published in Xenobiotica describes an innovative new method that predicts the routes and products of Phase I and II metabolism with high sensitivity and greater precision than other approaches.

AMSBIO announce the launch of a custom service providing access to a suite of powerful spatial biology multi-omics profiling tools.

Proteintech Genomics, a subsidiary of Proteintech Group, inc., and a provider of multiomic solutions for single-cell and spatial analysis, announced the launch of the MultiPro™ Human Fixed Cell Immune Profiling Antibody Cocktail.

Study confirms ALZmetrixTM whole blood test can detect people at high risk of developing full Alzheimer’s Disease.

Microarray-based solution enables deeper investigations of the humoral immune response in disease biology.

The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics.

The acquisition of multi-kilogram GMP and fill-finish capabilities enables the support of all phases of the
product life cycle from discovery to commercialisation.

AMSBIO announce a new range of pre-made Nano-Lantern lentivirus products that utilize a proprietary lentiviral vector system to enable highly sensitive and precise in vivo luminescence imaging.

Sapient has been awarded accreditation from the College of American Pathologists (CAP).

A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures.